Nippon Genetics and Bulldog Bio Create Alliance in North America
News Jul 18, 2013
Nippon Genetics Europe GmbH and Bulldog Bio have penned an agreement that assigns Bulldog Bio the sole right to sell many of Nippon Genetics’ electrophoresis and cell biology products to researchers in the USA.
Bulldog Bio in return will support, market, and stock their products.
“We’ve already seen early success with researchers adopting Nippon Genetics’ safe alternative to ethidium bromide which we began to sell early in the year.”
Ella Fontaine VP of Communications further elaborates “The feedback from many customers regarding Nippon Genetics wonderful line up of products has convinced us that there are many more labs that can benefit from these novel tools.”
The terms of this exclusive distribution contract have not been disclosed.
Watching Stem Cells Repair Spinal Cord in Real TimeNews
Clues to the reversal of brain and spine injury.READ MORE
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE